Physiologically Based Pharmacokinetic Modelling of Hyperforin to Predict Drug Interactions with St John’s Wort
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Physiologically Based Pharmacokinetic Modelling of Hyperforin to Predict Drug Interactions with St John’s Wort
Authors
Keywords
-
Journal
CLINICAL PHARMACOKINETICS
Volume -, Issue -, Pages -
Publisher
Springer Nature
Online
2019-01-25
DOI
10.1007/s40262-019-00736-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Predictive Performance of Physiologically-Based Pharmacokinetic Models in Predicting Drug–Drug Interactions Involving Enzyme Modulation
- (2018) Chia-Hsiang Hsueh et al. CLINICAL PHARMACOKINETICS
- A regulatory science viewpoint on botanical–drug interactions
- (2018) Manuela Grimstein et al. JOURNAL OF FOOD AND DRUG ANALYSIS
- Characterization of CYP2C Induction in Cryopreserved Human Hepatocytes and Its Application in the Prediction of the Clinical Consequences of the Induction
- (2018) Mika Nagai et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Understanding drug interactions with St John's wort (Hypericum perforatum L.): impact of hyperforin content
- (2018) Sigrun Chrubasik-Hausmann et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Clinical risks of St John’s Wort (Hypericum perforatum) co-administration
- (2017) Samaneh Soleymani et al. Expert Opinion on Drug Metabolism & Toxicology
- Clinical use of Hypericum perforatum (St John's wort) in depression: A meta-analysis
- (2017) Qin Xiang Ng et al. JOURNAL OF AFFECTIVE DISORDERS
- Development of a physiology-directed population pharmacokinetic and pharmacodynamic model for characterizing the impact of genetic and demographic factors on clopidogrel response in healthy adults
- (2016) Xi-Ling Jiang et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Optimizing pharmacokinetic bridging studies in paediatric oncology using physiologically-based pharmacokinetic modelling: application to docetaxel
- (2015) Hoai-Thu Thai et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- The Effect of St John’s Wort on the Pharmacokinetics of Docetaxel
- (2013) Andrew K. L. Goey et al. CLINICAL PHARMACOKINETICS
- The Utility of Modeling and Simulation in Drug Development and Regulatory Review
- (2013) Shiew-Mei Huang et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Application of permeability‐limited physiologically-based pharmacokinetic models: Part II-prediction of p‐glycoprotein mediated drug–drug interactions with digoxin
- (2013) Sibylle Neuhoff et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Predicting drug–drug interactions: application of physiologically based pharmacokinetic models under a systems biology approach
- (2013) Karen Rowland Yeo et al. Expert Review of Clinical Pharmacology
- C max and t max verification using Fibonacci sequence and absorption rate
- (2012) Tomasz Grabowski et al. EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS
- Potent mechanism-based inhibition of CYP3A4 by imatinib explains its liability to interact with CYP3A4 substrates
- (2011) AM Filppula et al. BRITISH JOURNAL OF PHARMACOLOGY
- Interplay of Metabolism and Transport in Determining Oral Drug Absorption and Gut Wall Metabolism: A Simulation Assessment Using the “Advanced Dissolution, Absorption, Metabolism (ADAM)” Model
- (2011) A. S. Darwich et al. CURRENT DRUG METABOLISM
- High Doses of Clopidogrel to Overcome Genetic Resistance
- (2011) Jean-Philippe Collet et al. JACC-Cardiovascular Interventions
- Metabolism of hyperforin, the active constituent of St. John's wort, in human liver microsomes
- (2010) Juho Hokkanen et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- The Effect of St Johnʼs Wort on the Pharmacodynamic Response of Clopidogrel in Hyporesponsive Volunteers and Patients: Increased Platelet Inhibition by Enhancement of CYP3A4 Metabolic Activity
- (2010) Wei C Lau et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Drug interaction between St John’s wort and zolpidem in healthy subjects
- (2010) Y. Hojo et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Sex Differences in Pharmacokinetics and Pharmacodynamics
- (2009) Offie P. Soldin et al. CLINICAL PHARMACOKINETICS
- Physiologically based mechanistic modelling to predict complex drug–drug interactions involving simultaneous competitive and time-dependent enzyme inhibition by parent compound and its metabolite in both liver and gut—The effect of diltiazem on the time-course of exposure to triazolam
- (2009) Karen Rowland Yeo et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Cytochrome P450 Turnover: Regulation of Synthesis and Degradation, Methods for Determining Rates, and Implications for the Prediction of Drug Interactions
- (2008) Jiansong Yang et al. CURRENT DRUG METABOLISM
- Clinical assessment of CYP2D6‐mediated herb–drug interactions in humans: Effects of milk thistle, black cohosh, goldenseal, kava kava, St. John's wort, andEchinacea
- (2008) Bill J. Gurley et al. MOLECULAR NUTRITION & FOOD RESEARCH
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started